Cargando…

Prognosis-Related Molecular Subtypes and Immune Features Associated with Hepatocellular Carcinoma

SIMPLE SUMMARY: Currently, there is no effective method to detect the prognosis for hepatocellular carcinoma (HCC). This study used bioinformatics techniques to determine HCC molecular subtypes and prognosis-related biomarkers. A total of 3330 intersectional differentially expressed genes (DEGs) wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Jiazhou, Lin, Yan, Gao, Xing, Lu, Lu, Huang, Xi, Huang, Shilin, Bai, Tao, Wu, Guobin, Luo, Xiaoling, Li, Yongqiang, Liang, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688639/ https://www.ncbi.nlm.nih.gov/pubmed/36428813 http://dx.doi.org/10.3390/cancers14225721

Ejemplares similares

Progress of research on molecular targeted therapies for colorectal cancer
por: Huang, Shilin, et al.
Publicado: (2023)

Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma
por: Liang, Rong, et al.
Publicado: (2021)

Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma
por: Liu, Ziyu, et al.
Publicado: (2019)

A Case of Curative Treatment with Apatinib and Camrelizumab Following Liver Resection for Advanced Hepatocellular Carcinoma
por: Huang, Julu, et al.
Publicado: (2023)

RBM38 Reverses Sorafenib Resistance in Hepatocellular Carcinoma Cells by Combining and Promoting lncRNA-GAS5
por: Gao, Xing, et al.
Publicado: (2023)

Prediction of Prognosis in Patients with Hepatocellular Carcinoma Based on Molecular Subtypes of Immune Genes
por: Du, Suming, et al.
Publicado: (2022)

Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma
por: Lin, Yan, et al.
Publicado: (2022)

Homologous Recombination Pathway Alternation Predicts Prognosis of Colorectal Cancer With Chemotherapy
por: Lin, Yan, et al.
Publicado: (2022)

Adjuvant transarterial chemoembolization to improve the prognosis of hepatocellular carcinoma following curative resection
por: Kuang, Xuejun, et al.
Publicado: (2018)

Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma
por: Zhang, Genhao
Publicado: (2022)

Circulating tumor cells and CXCR4 in the prognosis of hepatocellular carcinoma
por: Bai, Tao, et al.
Publicado: (2020)

Identification of a molecular subtyping system associated with the prognosis of Asian hepatocellular carcinoma patients receiving liver resection
por: Ma, Xiaohua, et al.
Publicado: (2019)

Signature construction and molecular subtype identification based on immune-related genes for better prediction of prognosis in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023)

Molecular subtypes based on DNA sensors predict prognosis and tumor immunophenotype in hepatocellular carcinoma
por: Lin, Hong-Sheng, et al.
Publicado: (2023)

Metaplastic breast cancer: Treatment and prognosis by molecular subtype
por: Hu, Jin, et al.
Publicado: (2021)

HDNA methylation data-based molecular subtype classification related to the prognosis of patients with hepatocellular carcinoma
por: He, Hui, et al.
Publicado: (2020)

Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates
por: Guo, Chengbin, et al.
Publicado: (2022)

Identification of novel lactate metabolism signatures and molecular subtypes for prognosis in hepatocellular carcinoma
por: Guan, Qiutong, et al.
Publicado: (2022)

Clinical prognosis and related molecular features of hepatitis B-associated adolescent and young adult hepatocellular carcinoma
por: Lv, Tao, et al.
Publicado: (2023)

Molecular subtypes and prognosis in RCC
por: Beuselinck, Benoit, et al.
Publicado: (2015)

Clinicopathological characteristics and features of molecular subtypes of breast cancer at high altitudes
por: Chen, Qi, et al.
Publicado: (2023)

Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer
por: Sheng, Hui, et al.
Publicado: (2019)

Signature construction and molecular subtype identification based on cuproptosis-related genes to predict the prognosis and immune activity of patients with hepatocellular carcinoma
por: Peng, Xingyu, et al.
Publicado: (2022)

Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2023)

DNA Damage Repair Profiles Alteration Characterize a Hepatocellular Carcinoma Subtype With Unique Molecular and Clinicopathologic Features
por: Lin, Peng, et al.
Publicado: (2021)

Associations of DDX60L With the Clinical Features and Prognosis of Hepatocellular Carcinoma
por: Ye, Ziqi, et al.
Publicado: (2022)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma
por: Liu, Chang, et al.
Publicado: (2022)

Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis
por: Zhang, Jinyan, et al.
Publicado: (2018)

Signature Construction and Molecular Subtype Identification Based on Pyroptosis-Related Genes for Better Prediction of Prognosis in Hepatocellular Carcinoma
por: Chen, Ji, et al.
Publicado: (2022)

Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma: Complement-associated molecular features in hepatocellular carcinoma
por: Huang, Run, et al.
Publicado: (2022)

RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
por: Ye, Jiazhou, et al.
Publicado: (2018)

Molecular subtyping based on immune cell marker genes predicts prognosis and therapeutic response in patients with lung adenocarcinoma
por: Liu, Zi-Tao, et al.
Publicado: (2023)

Integrative analysis identified two subtypes and a taurine-related signature to predict the prognosis and efficacy of immunotherapy in hepatocellular carcinoma
por: Lu, Qingsong, et al.
Publicado: (2023)

Construction of a Comprehensive Multiomics Map of Hepatocellular Carcinoma and Screening of Possible Driver Genes
por: Liu, Ziyu, et al.
Publicado: (2020)

Identification of immune related molecular subtypes and prognosis model for predicting prognosis, drug resistance in cervical squamous cell carcinoma
por: Hu, Dongzhi, et al.
Publicado: (2023)

Molecular subtyping of glioblastoma based on immune-related genes for prognosis
por: Chen, Xueran, et al.
Publicado: (2020)

Identification of immune subtypes and their prognosis and molecular implications in colorectal cancer
por: Sun, Yan, et al.
Publicado: (2022)

DNA methylation-based subtypes of acute myeloid leukemia with distinct prognosis and clinical features
por: Jian, Jimo, et al.
Publicado: (2023)

The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma
por: Li, Lunxu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_70oql0qsjbvmloiori3crtgaq6